BOSTON–(BUSINESS WIRE)–MPM BioImpact, a biotechnology investment firm creating and investing in innovative companies seeking to deliver transformative therapies to patients, today announced that Brian Shuster will join the Company as Entrepreneur Partner. Brian currently serves as Chief Business Officer of MPM BioImpact portfolio company Orna Therapeutics. “We are delighted to welcome Brian, a tenured biotechnology executive and expert in strategic business development, to MPM BioImpact. With